Latest Artificial Intelligence News

Page 13 of 107
icetana AI has started FY27 with a sharp lift in recurring revenue and quarterly sales, while its Antara Core platform reached its first commercial deployment. The progress came alongside higher operating cash outflows and a $3.9 million cash balance.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Blackpearl Group narrowed its quarterly EBITDAF loss to $2.97 million and is now targeting profitability in Q1 FY28. The company has also secured a non-binding US distribution agreement with a potential pipeline of more than 70 enterprise customers.
Sophie Babbage
Sophie Babbage
20 Oct 2026
MONEYME opened FY27 with stronger growth, record-low net credit losses and its third consecutive quarter of positive Normalised NPAT. The unaudited result supports the lender’s reaffirmed FY27 target of breakeven to $7 million, while its expanding unsecured portfolio remains an important test.
Claire Turing
Claire Turing
19 Oct 2026
Resimac Group delivered a stronger FY26, with normalised NPAT up 26% to $49.9 million and total assets under management reaching a record $16.5 billion. The result supports higher ordinary dividends, but the lender is still managing asset finance run-off, ASIC hardship proceedings and longer-term funding risks.
Claire Turing
Claire Turing
16 Oct 2026
Weebit Nano has begun silicon validation with a second customer whose chip is running software from integrated ReRAM, marking another step towards potential production in 2027. The company also added two AI customers, advanced qualification work and ended the quarter with A$164.2 million in cash.
Victor Sage
Victor Sage
16 Oct 2026
Fiducian Group delivered double-digit growth in underlying profit and lifted its fully franked dividend, despite a one-off $7.95 million ASIC penalty dragging statutory earnings lower. The wealth manager is also betting on AI-enabled adviser productivity and expansion of its external platform business.
Claire Turing
Claire Turing
15 Oct 2026
Integrated Research’s FY26 annual report confirms a sharp earnings deterioration, with revenue down 16% and net profit collapsing to A$1.2 million. A stronger cash balance and new AI products offer financial resilience, but FY27 now hinges on turning product launches into commercial adoption.
Sophie Babbage
Sophie Babbage
14 Oct 2026
Clever Culture Systems has appointed PSC Biotech as its sole sales agent for APAS Independence across pharmaceutical manufacturing markets in the US, Canada and Singapore. The agreement expands CCS’s reach beyond its direct focus on major global drugmakers, but any material revenue uplift is not expected before FY28.
Victor Sage
Victor Sage
14 Oct 2026
InteliCare Holdings Limited (ASX:ICR) used FY2026 to move from pilot projects into contracted deployment, led by an estimated $8.8 million five-year agreement with mecwacare. Revenue and customer receipts more than doubled, although the company remains loss-making and reliant on disciplined rollout execution and further funding.
Victor Sage
Victor Sage
13 Oct 2026
COSOL’s revenue fell 15.6% in FY26 and the ASX-listed asset management technology company swung to a $4.0 million statutory loss after goodwill impairments. Management is betting that leaner operations, new transport contracts and AI-led services can restore profitable growth, but the recovery still needs to show up in revenue.
Victor Sage
Victor Sage
13 Oct 2026
WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.
Sophie Babbage
Sophie Babbage
13 Oct 2026
Vection Technologies has secured a multi-year framework agreement with Italian telecommunications provider Retelit Digital Service, which has committed to generate at least approximately A$19.5 million in revenue for the company by June 2030. The deal expands Vection’s route into enterprise customers across Italy and Europe, although margins and payment terms remain undisclosed.
Sophie Babbage
Sophie Babbage
13 Oct 2026

Browse the archive

Full archive